Dipeptidyl peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Mechanisms and Efficacy in Clinical Practice
نویسندگان
1 Department of Clinical Biochemistry, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
doi
10.18502/ijdo.v18i1.21063چکیده
Type 2 diabetes mellitus (T2DM) is a long-term metabolic condition marked by reduced insulin release, decreased sensitivity to insulin, and hyperglucagonemia. In recent years, dipeptidyl peptidase-4 (DPP-4) inhibitors have become increasingly significant within the newer classes of antidiabetic medications, thanks to their distinct mechanism of action, advantageous safety profile, and the convenience ...